Citation
Select
AVERROES Steering Committee and Investigators, Connolly SJ, Eikelboom J, Joyner C, Diener HC, Hart R, Golitsyn S, Flaker G, Avezum A, Hohnloser SH, Diaz R, Talajic M, Zhu J, Pais P, Budaj A, Parkhomenko A, Jansky P, Commerford P, Tan RS, Sim KH, Lewis BS, Van Mieghem W, Lip GY, Kim JH, Lanas-Zanetti F, Gonzalez-Hermosillo A, Dans AL, Munawar M, O,Donnell M, Lawrence J, Lewis G, Afzal R, Yusuf S
Apixaban in Patients with Atrial Fibrillation
N Engl J Med. 2011 Feb 10. [Epub ahead of print]
Citation
Select
Olesen JB, Lip GY, Hansen ML, Hansen PR, Tolstrup JS, Lindhardsen J, Selmer C, Ahlehoff O, Olsen AM, Gislason GH, Torp-Pedersen C
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study
BMJ. 2011 Jan 31;342:d124. doi: 10.1136/bmj.d124